Your Health. Your Family. Your Choice.
Administered by: Pharmacy Purchased by: ?
Life Threatening? No
Write-up: Swollen supraclavicular lymph node (right); Fever; Muscle aches; Headache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 30135BA) via an unspecified route of administration in the right arm on 11Sep2021 at 12:45 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history was unknown. The patient had no known allergies. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FD8448) via an unspecified route of administration in the right arm on 20Aug2021 at 09:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. On 12Sep2021 at 01:15, the patient experienced swollen supraclavicular lymph node (right), fever, muscle aches, headache, and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events swollen supraclavicular lymph node (right), fever, muscle aches, headache, and fatigue were not resolved at the time of this report.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166